{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:26:01Z","timestamp":1790961961963,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120240325"],"award-info":[{"award-number":["22120240325"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2023CRS020"],"award-info":[{"award-number":["SHDC2023CRS020"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172706"],"award-info":[{"award-number":["82172706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373274"],"award-info":[{"award-number":["82373274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114405","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:17:19Z","timestamp":1763590639000},"page":"114405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dendritic cell-derived biomimetic vesicles as cancer vaccine platforms for melanoma immunotherapy"],"prefix":"10.1016","volume":"389","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114405_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114405_bb0010","doi-asserted-by":"crossref","first-page":"18801","DOI":"10.1021\/acsnano.4c05065","article-title":"Components, formulations, deliveries, and combinations of tumor vaccines","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114405_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114405_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4639","article-title":"An implantable blood clot-based immune niche for enhanced cancer vaccination","volume":"6","author":"Fan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114405_bb0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114405_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114405_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114405_bb0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","article-title":"Vaccines as treatments for prostate cancer","volume":"20","author":"Rastogi","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114405_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1259562","article-title":"Dendritic cell vaccine of gliomas: challenges from bench to bed","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0070","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New Technologies for Analysis of extracellular vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114405_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114405_bb0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance","volume":"18","author":"Maacha","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114405_bb0100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","article-title":"Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading","volume":"31","author":"R\u00e4dler","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114405_bb0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","article-title":"Extracellular vesicles and nanoparticles: emerging complexities","volume":"33","author":"Jeppesen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0110","article-title":"Engineered extracellular vesicles for Cancer therapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114405_bb0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114405_bb0120","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.apsb.2022.03.017","article-title":"An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114405_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00262-024-03776-5","article-title":"GP100 expression is variable in intensity in melanoma","volume":"73","author":"Mann","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.114405_bb0130","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","article-title":"Immunotherapy resistance by inflammation-induced dedifferentiation","volume":"8","author":"Mehta","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.114405_bb0135","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1158\/1078-0432.CCR-08-2806","article-title":"Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood","volume":"15","author":"Walker","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114405_bb0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-0095-03","article-title":"gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells","volume":"10","author":"Walker","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114405_bb0145","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1200\/JCO.2007.13.3165","article-title":"Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma","volume":"26","author":"Sosman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0150","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114405_bb0155","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.2007.15.7826","article-title":"Combining a peptide vaccine with high-dose interleukin-2","volume":"26","author":"Chapman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-020-01250-1","article-title":"Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114405_bb0165","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.7150\/thno.37574","article-title":"STING activation in cancer immunotherapy","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114405_bb0170","doi-asserted-by":"crossref","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","article-title":"Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for Cancer immunotherapy","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114405_bb0175","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2025.114405_bb0180","article-title":"Whither vaccines?","volume":"74","author":"Rodrigues","year":"2017","journal-title":"J. Infect."},{"key":"10.1016\/j.jconrel.2025.114405_bb0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114405_bb0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114405_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41590-021-00896-3","article-title":"The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-\u03b2 pathway","volume":"22","author":"Takahashi","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","article-title":"Lactobacillus rhamnosus GG induces cGAS\/STING- dependent type I interferon and improves response to immune checkpoint blockade","volume":"71","author":"Si","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114405_bb0205","article-title":"Activation of the cGAS-STING-IRF3 Axis by type I and II interferons contributes to host defense","volume":"11","author":"Tong","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2025.114405_bb0210","article-title":"Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS\/STING\/IFN-mediated nucleic acid sensing","volume":"219","author":"Kessler","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114405_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.03.005","article-title":"Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway","volume":"58","author":"Lai","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114405_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s44318-024-00291-2","article-title":"STING induces HOIP-mediated synthesis of M1 ubiquitin chains to stimulate NF-\u03baB signaling","volume":"44","author":"Fischer","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.114405_bb0225","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114405_bb0230","article-title":"Engineered probiotic-based personalized Cancer vaccine potentiates antitumor immunity through initiating trained immunity","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2025.114405_bb0235","article-title":"Acid-ionizable iron nanoadjuvant augments STING activation for personalized vaccination immunotherapy of cancer","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114405_bb0240","article-title":"Development of Mannosylated lipid nanoparticles for mRNA Cancer vaccine with high antigen presentation efficiency and immunomodulatory capability","volume":"63","author":"Lei","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114405_bb0245","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.cell.2024.03.008","article-title":"NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks","volume":"187","author":"David","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114405_bb0250","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114405_bb0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.semcancer.2019.08.001","article-title":"Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy","volume":"59","author":"Queirolo","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0260","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114405_bb0265","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","article-title":"Network-based machine learning approach to predict immunotherapy response in cancer patients","volume":"13","author":"Kong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114405_bb0270","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.cell.2023.06.002","article-title":"Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity","volume":"186","author":"Ma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114405_bb0275","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114405_bb0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114405_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189068","article-title":"Advances and prospects of mRNA vaccines in cancer immunotherapy","volume":"1879","author":"Liu","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114405_bb0290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2023.11.003","article-title":"The potential of mRNA vaccines in cancer nanomedicine and immunotherapy","volume":"45","author":"Pan","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: a journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114405_bb0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41590-020-0635-3","article-title":"Lymph node stromal cells: cartographers of the immune system","volume":"21","author":"Krishnamurty","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0305","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","article-title":"Same yet different - how lymph node heterogeneity affects immune responses","volume":"24","author":"Cruz de Casas","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0310","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.immuni.2023.07.008","article-title":"Lymph node sharing between pancreas, gut, and liver leads to immune crosstalk and regulation of pancreatic autoimmunity","volume":"56","author":"Brown","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114405_bb0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2016.12.011","article-title":"Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses","volume":"46","author":"Druzd","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114405_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.05.002","article-title":"Visualizing synaptic transfer of tumor antigens among dendritic cells","volume":"37","author":"Ruhland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114405_bb0325","doi-asserted-by":"crossref","first-page":"18214","DOI":"10.1021\/acsnano.4c17712","article-title":"Artificial Tolerogenic dendritic cell-derived vesicles prepared by high-pressure homogenization for potent immunotherapy of type 1 diabetes","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114405_bb0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12951-024-02470-z","article-title":"Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy","volume":"22","author":"Lin","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0335","article-title":"Polysaccharide-modified liposome-based drug delivery system for cancer targeted therapy: an updated review","volume":"148236","author":"Zhu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2025.114405_bb0340","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cac2.12596","article-title":"Dysfunction of dendritic cells in tumor microenvironment and immunotherapy","volume":"44","author":"Chen","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.jconrel.2025.114405_bb0345","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-022-01561-5","article-title":"Reprogramming the tumor microenvironment by genome editing for precision cancer therapy","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114405_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105301","article-title":"Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective","volume":"107","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2025.114405_bb0355","article-title":"Tumor therapy strategies based on microenvironment-specific responsive nanomaterials","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114405_bb0360","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/med.22072","article-title":"Targeting tumor microenvironment with photodynamic nanomedicine","volume":"45","author":"Modi","year":"2025","journal-title":"Med. Res. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:38:01Z","timestamp":1781325481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":72,"alternative-id":["S0168365925010193"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114405","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell-derived biomimetic vesicles as cancer vaccine platforms for melanoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114405"}}